The Hepatitis B Vaccine market is a subset of the larger Infectious Disease Testing market. It is focused on the prevention of Hepatitis B, a viral infection that can cause serious liver damage. The vaccine is typically administered to infants and young children, as well as adults at risk of infection. The vaccine is also recommended for healthcare workers and those with multiple sexual partners. The market is driven by the need to protect vulnerable populations from the virus, as well as the increasing prevalence of the disease in certain regions. Companies in the Hepatitis B Vaccine market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, and Pfizer. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.